… quadrivalent HPV vaccine were effective against genital warts in our population. Moreover,
with low vaccine coverage the incidence of genital warts decreased only in the vaccinated. …

… human papillomavirus (HPV) vaccine has been assumed to give protection against genital
warts (GW) as well as cervical cancer. Our main question was whether HPV vaccine has any …

… To assess the effectiveness of the HPV vaccines in preventing genital warts (GW) in women
aged 14–23 years and to estimate the incidence of GW in the whole population aged from …

… Genital warts caused by HPV 6 and 11 have a lifetime risk of acquisition of 10%. HPV vaccines
are subunit vaccines … Two vaccines have been licenced since 2006/2007 and are in the …

… HPV 6 and 11 cause 85% of all genital warts and some low-grade lesions at various sites. …
HPV vaccine and later in the nonavalent vaccine. Once more than one HPV vaccine was …

… of HPV vaccine in preventing the relapse of ano-genital warts. The results suggest that HPV
vaccination does not provide secondary benefit in patients with previous ano-genital warts. …

… genital warts after primary carbon dioxide laser treatment before the introduction of the
vaccination against HPV. … recurrence rates of genital warts before HPV vaccination and underline …

… decreasing HPV infection and related diseases, such as warts … about current HPV vaccines,
focusing on vaccine coverage … genital warts caused by the HPV types covered by Gardasil [9,…

… of a nonavalent HPV vaccination for treatment of genital warts because the vaccine may
be beneficial as an alternative noninvasive treatment of recalcitrant genital warts. However, …

… . Rapid decline in presentations of genital warts after the implementation of a national
quadrivalent human papillomavirus vaccination programme for young women. Sex Transm Infect …